Evidence map›Paper›PMID 18832071›Full record

ArticleGenes & development2008

The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression.

Efrat Shema, Itay Tirosh, Yael Aylon, Jing Huang, Chaoyang Ye, Neta Moskovits, Nina Raver-Shapira, Neri Minsky, Judith Pirngruber, Gabi Tarcic and 9 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Genes & development, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 184 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 1 synthesis or guideline pooled it, 285 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Decoding RNF20: an epigenetic modifier and beyond.Frontiers in cell and developmental biology · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Histone H2B ubiquitylation: Connections to transcription and effects on chromatin structure.Biochimica et biophysica acta. Gene regulatory mechanisms · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. RNF20 contributes to epigenetic immunosuppression through CDK9-dependent LSD1 stabilization.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Article
  19. Review
  20. Article

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Efrat ShemaDepartment of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel.
Itay Tirosh
Yael Aylon
Jing Huang
Chaoyang Ye
Neta Moskovits
Nina Raver-Shapira
Neri Minsky
Judith Pirngruber
Gabi Tarcic
Pavla Hublarova
Lilach Moyal
Mali Gana-Weisz
Yosef Shiloh
Yossef Yarden
Steven A Johnsen
Borivoj Vojtesek
Shelley L Berger
Moshe Oren
Weizmann Institute of Science · ILTel Aviv University · ILThe Wistar Institute · USMasaryk Memorial Cancer Institute · CZ

Funding

Role of PCAF/GCN5 Acetylation on p53 TransactivationR01CA078831 · NCI · WISTAR INSTITUTE · PI BERGER, SHELLEY L · 1999 to 2022
$7.8M
Functional analysis of the p53 tumor suppressorR37CA040099 · NCI · WEIZMANN INSTITUTE OF SCIENCE · PI OREN, MOSHE · 2003 to 2012
$2.2M
NCI NIH HHS R01 CA078831NCI NIH HHS R37 CA040099NCI NIH HHS R37 CA40099
6 · The paper itself

Abstract

Histone monoubiquitylation is implicated in critical regulatory processes. We explored the roles of histone H2B ubiquitylation in human cells by reducing the expression of hBRE1/RNF20, the major H2B-specific E3 ubiquitin ligase. While H2B ubiquitylation is broadly associated with transcribed genes, only a subset of genes was transcriptionally affected by RNF20 depletion and abrogation of H2B ubiquitylation. Gene expression dependent on RNF20 includes histones H2A and H2B and the p53 tumor suppressor. In contrast, RNF20 suppresses the expression of several proto-oncogenes, which reside preferentially in closed chromatin and are modestly transcribed despite bearing marks usually associated with high transcription rates. Remarkably, RNF20 depletion augmented the transcriptional effects of epidermal growth factor (EGF), increased cell migration, and elicited transformation and tumorigenesis. Furthermore, frequent RNF20 promoter hypermethylation was observed in tumors. RNF20 may thus be a putative tumor suppressor, acting through selective regulation of a distinct subset of genes.

Indexed as

AnimalsBreast NeoplasmsCell MovementCell Transformation, NeoplasticChromatinDNA MethylationDNA, NeoplasmEpidermal Growth FactorFemaleGene Expression RegulationHeLa CellsHistonesHumansMiceMice, NudePromoter Regions, GeneticChromatinDNA, NeoplasmEpidermal Growth FactorHistonesRNA Polymerase IIRNA, Small InterferingRNF20 protein, humanRNF20 protein, mouseTP53 protein, humanTumor Suppressor Protein p53Tumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID18832071
PMCPMC2559905
OpenAlexW2103395279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.